Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention
A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women.
- Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention
A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women.
- Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention
A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women.
- Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention
A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women.
- Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention
A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women.
- Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention
A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women.
- Cran-Max Found Comparable to Antibiotics For UTI Treatment and Prevention
A recent study published in the Journal of Antimicrobial Chemotherapy has shown that the administration of Cran-Max®, a proprietary cranberry concentrate, was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women.
- Even with Breast Cancer, Healthy Diet Counts
- Even with Breast Cancer, Healthy Diet Counts
- Even with Breast Cancer, Healthy Diet Counts
- Even with Breast Cancer, Healthy Diet Counts
- Even with Breast Cancer, Healthy Diet Counts
- Even with Breast Cancer, Healthy Diet Counts
- Even with Breast Cancer, Healthy Diet Counts
- Even with Breast Cancer, Healthy Diet Counts
- Intake of Certain Fatty Acid Appears to Improve Neurodevelopment for Preterm Girls, But Not Boys
Preterm infant girls who received a high amount of dietary docosahexaenoic acid (DHA; an omega-3 fatty acid) had higher measures of neurodevelopment than preterm girls who received a standard amount of DHA, but this effect was not seen among preterm boys, according to a study in the January 14 issue of JAMA.
- Intake of Certain Fatty Acid Appears to Improve Neurodevelopment for Preterm Girls, But Not Boys
Preterm infant girls who received a high amount of dietary docosahexaenoic acid (DHA; an omega-3 fatty acid) had higher measures of neurodevelopment than preterm girls who received a standard amount of DHA, but this effect was not seen among preterm boys, according to a study in the January 14 issue of JAMA.
- Intake of Certain Fatty Acid Appears to Improve Neurodevelopment for Preterm Girls, But Not Boys
Preterm infant girls who received a high amount of dietary docosahexaenoic acid (DHA; an omega-3 fatty acid) had higher measures of neurodevelopment than preterm girls who received a standard amount of DHA, but this effect was not seen among preterm boys, according to a study in the January 14 issue of JAMA.
- Intake of Certain Fatty Acid Appears to Improve Neurodevelopment for Preterm Girls, But Not Boys
Preterm infant girls who received a high amount of dietary docosahexaenoic acid (DHA; an omega-3 fatty acid) had higher measures of neurodevelopment than preterm girls who received a standard amount of DHA, but this effect was not seen among preterm boys, according to a study in the January 14 issue of JAMA.
- Intake of Certain Fatty Acid Appears to Improve Neurodevelopment for Preterm Girls, But Not Boys
Preterm infant girls who received a high amount of dietary docosahexaenoic acid (DHA; an omega-3 fatty acid) had higher measures of neurodevelopment than preterm girls who received a standard amount of DHA, but this effect was not seen among preterm boys, according to a study in the January 14 issue of JAMA.
- Intake of Certain Fatty Acid Appears to Improve Neurodevelopment for Preterm Girls, But Not Boys
Preterm infant girls who received a high amount of dietary docosahexaenoic acid (DHA; an omega-3 fatty acid) had higher measures of neurodevelopment than preterm girls who received a standard amount of DHA, but this effect was not seen among preterm boys, according to a study in the January 14 issue of JAMA.
- Carlson Laboratories Supports the American Heart Association's Go Red for Women Campaign
Go Red for Women is the American Heart Association's campaign to raise awareness regarding cardiovascular disease in women. As part of their campaign, February 6th, 2009 is National Wear Red Day.
- Carlson Laboratories Supports the American Heart Association's Go Red for Women Campaign
Go Red for Women is the American Heart Association's campaign to raise awareness regarding cardiovascular disease in women. As part of their campaign, February 6th, 2009 is National Wear Red Day.
- Carlson Laboratories Supports the American Heart Association's Go Red for Women Campaign
Go Red for Women is the American Heart Association's campaign to raise awareness regarding cardiovascular disease in women. As part of their campaign, February 6th, 2009 is National Wear Red Day.
- Carlson Laboratories Supports the American Heart Association's Go Red for Women Campaign
Go Red for Women is the American Heart Association's campaign to raise awareness regarding cardiovascular disease in women. As part of their campaign, February 6th, 2009 is National Wear Red Day.
- Carlson Laboratories Supports the American Heart Association's Go Red for Women Campaign
Go Red for Women is the American Heart Association's campaign to raise awareness regarding cardiovascular disease in women. As part of their campaign, February 6th, 2009 is National Wear Red Day.
- Girls: Exercise Now for Bones that Last
- Girls: Exercise Now for Bones that Last
- Girls: Exercise Now for Bones that Last
- Girls: Exercise Now for Bones that Last
- Girls: Exercise Now for Bones that Last
- Girls: Exercise Now for Bones that Last
- Girls: Exercise Now for Bones that Last
- Girls: Exercise Now for Bones that Last
- Girls: Exercise Now for Bones that Last
- Soy May Reduce Risk of Colorectal Cancer
A new study published in the American Journal of Clinical Nutrition explores how soyfood consumption may lower the risk of colorectal cancer, or cancer of the colon or rectum, in postmenopausal women.
- Soy May Reduce Risk of Colorectal Cancer
A new study published in the American Journal of Clinical Nutrition explores how soyfood consumption may lower the risk of colorectal cancer, or cancer of the colon or rectum, in postmenopausal women.
- Soy May Reduce Risk of Colorectal Cancer
A new study published in the American Journal of Clinical Nutrition explores how soyfood consumption may lower the risk of colorectal cancer, or cancer of the colon or rectum, in postmenopausal women.
- Soy May Reduce Risk of Colorectal Cancer
A new study published in the American Journal of Clinical Nutrition explores how soyfood consumption may lower the risk of colorectal cancer, or cancer of the colon or rectum, in postmenopausal women.
- Evidence Lacking in Multivitamin Study of Women's Risk of Cancer, Heart Disease or Death, Says Natural Products Association
A new published study claiming that multivitamin use by postmenopausal women does little to improve their risk of mortality fails to take into account important dietary factors or accurately grasp how dietary supplements and health claims are regulated by the U.S. Food and Drug Administration says the NPA.
- Evidence Lacking in Multivitamin Study of Women's Risk of Cancer, Heart Disease or Death, Says Natural Products Association
A new published study claiming that multivitamin use by postmenopausal women does little to improve their risk of mortality fails to take into account important dietary factors or accurately grasp how dietary supplements and health claims are regulated by the U.S. Food and Drug Administration says the NPA.
- Evidence Lacking in Multivitamin Study of Women's Risk of Cancer, Heart Disease or Death, Says Natural Products Association
A new published study claiming that multivitamin use by postmenopausal women does little to improve their risk of mortality fails to take into account important dietary factors or accurately grasp how dietary supplements and health claims are regulated by the U.S. Food and Drug Administration says the NPA.
- Evidence Lacking in Multivitamin Study of Women's Risk of Cancer, Heart Disease or Death, Says Natural Products Association
A new published study claiming that multivitamin use by postmenopausal women does little to improve their risk of mortality fails to take into account important dietary factors or accurately grasp how dietary supplements and health claims are regulated by the U.S. Food and Drug Administration says the NPA.
- Evidence Lacking in Multivitamin Study of Women's Risk of Cancer, Heart Disease or Death, Says Natural Products Association
A new published study claiming that multivitamin use by postmenopausal women does little to improve their risk of mortality fails to take into account important dietary factors or accurately grasp how dietary supplements and health claims are regulated by the U.S. Food and Drug Administration says the NPA.
- Vitamin K2 May Help Reduce Women's Risk of Coronary Heart Disease
NattoPharma and PL Thomas has announced a new publication by G. Gast et al., in the journal Nutrition, Metabolism and Cardiovascular Diseases that posted online January 28, 2009 confirming the importance of high menaquinone (Vitamin K2) intake for human cardiovascular health.
- Vitamin K2 May Help Reduce Women's Risk of Coronary Heart Disease
NattoPharma and PL Thomas has announced a new publication by G. Gast et al., in the journal Nutrition, Metabolism and Cardiovascular Diseases that posted online January 28, 2009 confirming the importance of high menaquinone (Vitamin K2) intake for human cardiovascular health.
- Vitamin K2 May Help Reduce Women's Risk of Coronary Heart Disease
NattoPharma and PL Thomas has announced a new publication by G. Gast et al., in the journal Nutrition, Metabolism and Cardiovascular Diseases that posted online January 28, 2009 confirming the importance of high menaquinone (Vitamin K2) intake for human cardiovascular health.
- Vitamin K2 May Help Reduce Women's Risk of Coronary Heart Disease
NattoPharma and PL Thomas has announced a new publication by G. Gast et al., in the journal Nutrition, Metabolism and Cardiovascular Diseases that posted online January 28, 2009 confirming the importance of high menaquinone (Vitamin K2) intake for human cardiovascular health.
- Vitamin K2 May Help Reduce Women's Risk of Coronary Heart Disease
NattoPharma and PL Thomas has announced a new publication by G. Gast et al., in the journal Nutrition, Metabolism and Cardiovascular Diseases that posted online January 28, 2009 confirming the importance of high menaquinone (Vitamin K2) intake for human cardiovascular health.
- Vitamin K2 May Help Reduce Women's Risk of Coronary Heart Disease
NattoPharma and PL Thomas has announced a new publication by G. Gast et al., in the journal Nutrition, Metabolism and Cardiovascular Diseases that posted online January 28, 2009 confirming the importance of high menaquinone (Vitamin K2) intake for human cardiovascular health.
- Moms-to-Be: Keep an Eye on Surprise Sources of Mercury
- Moms-to-Be: Keep an Eye on Surprise Sources of Mercury
- Moms-to-Be: Keep an Eye on Surprise Sources of Mercury
- Moms-to-Be: Keep an Eye on Surprise Sources of Mercury
- Moms-to-Be: Keep an Eye on Surprise Sources of Mercury
- Moms-to-Be: Keep an Eye on Surprise Sources of Mercury
- Moms-to-Be: Keep an Eye on Surprise Sources of Mercury
- Moms-to-Be: Keep an Eye on Surprise Sources of Mercury
- Moms-to-Be: Keep an Eye on Surprise Sources of Mercury
- Optihealth Inc. Re-Formulates its Menopause Formula Adding GeniVida™
Optihealth Inc., has announced the re-formulation and re-launch of its Menopause Formula, now called Menopause Ultra, which includes GeniVida™ from DSM Nutritional Products Inc.
- Optihealth Inc. Re-Formulates its Menopause Formula Adding GeniVida™
Optihealth Inc., has announced the re-formulation and re-launch of its Menopause Formula, now called Menopause Ultra, which includes GeniVida™ from DSM Nutritional Products Inc.
- Optihealth Inc. Re-Formulates its Menopause Formula Adding GeniVida™
Optihealth Inc., has announced the re-formulation and re-launch of its Menopause Formula, now called Menopause Ultra, which includes GeniVida™ from DSM Nutritional Products Inc.
- Optihealth Inc. Re-Formulates its Menopause Formula Adding GeniVida™
Optihealth Inc., has announced the re-formulation and re-launch of its Menopause Formula, now called Menopause Ultra, which includes GeniVida™ from DSM Nutritional Products Inc.
- Optihealth Inc. Re-Formulates its Menopause Formula Adding GeniVida™
Optihealth Inc., has announced the re-formulation and re-launch of its Menopause Formula, now called Menopause Ultra, which includes GeniVida™ from DSM Nutritional Products Inc.
- Ostera™: Nutraceutical Addresses an Unfilled Gap in Postmenopausal Bone Health
Metagenics, Inc., has announced that it has launched a new nutraceutical called Ostera, a product intended to help support the special needs of postmenopausal women, whose bone health may be affected by declining estrogen levels.
- Ostera™: Nutraceutical Addresses an Unfilled Gap in Postmenopausal Bone Health
Metagenics, Inc., has announced that it has launched a new nutraceutical called Ostera, a product intended to help support the special needs of postmenopausal women, whose bone health may be affected by declining estrogen levels.
- Ostera™: Nutraceutical Addresses an Unfilled Gap in Postmenopausal Bone Health
Metagenics, Inc., has announced that it has launched a new nutraceutical called Ostera, a product intended to help support the special needs of postmenopausal women, whose bone health may be affected by declining estrogen levels.
- Ostera™: Nutraceutical Addresses an Unfilled Gap in Postmenopausal Bone Health
Metagenics, Inc., has announced that it has launched a new nutraceutical called Ostera, a product intended to help support the special needs of postmenopausal women, whose bone health may be affected by declining estrogen levels.
- Ostera™: Nutraceutical Addresses an Unfilled Gap in Postmenopausal Bone Health
Metagenics, Inc., has announced that it has launched a new nutraceutical called Ostera, a product intended to help support the special needs of postmenopausal women, whose bone health may be affected by declining estrogen levels.
- Ostera™: Nutraceutical Addresses an Unfilled Gap in Postmenopausal Bone Health
Metagenics, Inc., has announced that it has launched a new nutraceutical called Ostera, a product intended to help support the special needs of postmenopausal women, whose bone health may be affected by declining estrogen levels.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
- GMP Labs Expands Liquid Nutraceutical Capabilities
- What Parents Should Know About Kids and Supplements
- What Parents Should Know About Kids and Supplements
- Oats Beat Back Cholesterol
- Oats Beat Back Cholesterol
- Seniors: Pump Up for Strong Bones and Heart
- Seniors: Pump Up for Strong Bones and Heart
- Vitamin K2 as MK-7 (MenaQ7®) supplementation - essential for better bone health after organ transplantation
- Vitamin K2 as MK-7 (MenaQ7®) supplementation - essential for better bone health after organ transplantation
|
Omega-3s ease psychological distress and depressive symptoms often suffered by menopausal and perimenopausal women, according to researchers at Université Laval's Faculty of Medicine. Their study, published in the February issue of The American Journal of Clinical Nutrition, presents the first evidence that omega-3 supplements are effective for treating common menopause-related mental health problems.
Dr. Michel Lucas and colleagues recruited 120 women age 40 to 55 and divided them into two groups. Women in the first group took three gel capsules containing a total of one gram of EPA, an omega-3 fatty acid of marine origin, every day for eight weeks. Those in the second group followed the same protocol, but took gel capsules containing sunflower oil without EPA.
Test results before and after the eight-week period indicate that omega-3s significantly improved the condition of women suffering symptoms of psychological distress and mild depression. "The differences we observed between the two groups are noteworthy," commented Dr Lucas, "especially considering that omega-3s have very few side effects and are beneficial to cardiovascular health." However, no positive effect was observed among a small group of women with more severe depressive symptoms.
Women with hot flashes also noted that their condition improved after consuming omega-3s. At baseline, the number of daily hot flashes was 2.8 and dropped by an average of 1.6 in the group taking omega-3s and by 0.5 in the control group. The change that can be attributed to the use of omega-3s, i.e. a decrease of 1.1 hot flashes per day, is equivalent to results obtained with hormone therapy and antidepressants. Details of these results were published in the November 20, 2008 online edition of the journal Menopause.
Many women suffer from depressive symptoms during menopause and perimenopause. Some take antidepressants for relief even though their effectiveness is controversial. Mistrust of hormone therapy and antidepressants leads certain women to turn to alternative methods whose effectiveness has not yet been scientifically demonstrated. This study by Université Laval researchers corrects this situation with regard to marine-sourced omega-3s.
The following researchers coauthored this study with Michel Lucas: Geneviève Asselin and Sylvie Dodin from the Lucie and André Chagnon Chair for the Teaching of an Integrated Approach in Prevention, as well as Chantal Mérette and Marie-Josée Poulin from Université Laval Robert-Giffard Research Center.
Information:
Dr. Michel Lucas
Lucie and André Chagnon Chair for the Teaching of an Integrated Approach in Prevention
Université Laval
Tel.: 418-525-4444, ext. 46529 |